Persister cancer cells: Iron addiction and vulnerability to ferroptosis.
Mol. Cell 82, 728-740 (2022)
Ferroptosis is a unique type of non-apoptotic cell death resulting from the unrestrained occurrence of peroxidized phospholipids, which are subject to iron-mediated production of lethal oxygen radicals. This cell death modality has been detected across many organisms, including in mammals, where it can be used as a defense mechanism against pathogens or even harnessed by T cells to sensitize tumor cells toward effective killing. Conversely, ferroptosis is considered one of the main cell death mechanisms promoting degenerative diseases. Emerging evidence suggests that ferroptosis represents a vulnerability in certain cancers. Here, we critically review recent advances linking ferroptosis vulnerabilities of dedifferentiating and persister cancer cells to the dependency of these cells on iron, a potential Achilles heel for small-molecule intervention. We provide a perspective on the mechanisms reliant on iron that contribute to the persister cancer cell state and how this dependency may be exploited for therapeutic benefits.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Review
Thesis type
Editors
Keywords
Glutathione-peroxidase 4; Cystine/glutamate Antiporter; Promotes Ferroptosis; Lipid-peroxidation; Oxidative Stress; Stem-cells; Death; Inhibition; Mechanism; Complex
Keywords plus
Language
english
Publication Year
2022
Prepublished in Year
2021
HGF-reported in Year
2021
ISSN (print) / ISBN
1097-2765
e-ISSN
1097-4164
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 82,
Issue: 4,
Pages: 728-740
Article Number: ,
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-506900-001
Grants
Else Kroner-Fresenius-Stiftung
Fondation Charles Defforey-Institut de France
Ligue contre le Cancer
Region Ile-de-France
National Cancer Institute's Cancer Target Discovery and Development (CTD2) Network
Deutsche Forschungsgemeinschaft (DFG)
German Federal Ministry of Education and Research (BMBF) VIP+ program NEURO-PROTEKT
Ministry of Science and Higher Education of The Russian Federation
ERC under the European Union's Horizon 2020 research and innovation program
European Research Council (ERC) under the European Union
Copyright
Erfassungsdatum
2022-01-21